Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI

Question Could Dynamic Contrast-Enhanced (DCE) MRI offer a safe and non-invasive way to assess Programmed Death-Ligand 1 (PD-L1) expression? Findings Quantitative DCE-MRI parameters K<sup>trans</sup> (the volume transfer rate) and K<sub>ep</sub> (the efflux rate constant) show potential for distinguishing PD-L1 hyperexpression from hypoexpression. Clinical relevance Preliminary results suggest that DCE-MRI could be a safe method to stratify PD-L1 hypo/hyperexpression in non-small cell lung cancer, potentially optimizing treatment decisions, given the high cost of immunotherapy.

Authors

Institutions

Publication Details

Journal
European Radiology
Published
2025-03-27
DOI
https://doi.org/10.1007/s00330-025-11524-1
Citations
3
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
4.08

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI

Raffaella Fiamma Cabini, Lorenzo Preda, Francesco Agustoni, Andrea Riccardo Filippi et al.
3 citations
European Radiology
Radiomics and Machine Learning in Medical Imaging
4.08
article

Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI

Raffaella Fiamma Cabini, Lorenzo Preda, Francesco Agustoni, Andrea Riccardo Filippi, Sithin Thulasi Seetha, Agnese Robustelli Test, Jessica Saddi, Giulia Maria Stella, Francesco Sanvito, Domenico Zacà, Gaia Messana, Francesca Brero, Alessandro Lascialfari, Chandra Bortolotto, Alessandra Marrocco, Carlotta Pairazzi
article en
3 citations

Abstract

Question Could Dynamic Contrast-Enhanced (DCE) MRI offer a safe and non-invasive way to assess Programmed Death-Ligand 1 (PD-L1) expression? Findings Quantitative DCE-MRI parameters K<sup>trans</sup> (the volume transfer rate) and K<sub>ep</sub> (the efflux rate constant) show potential for distinguishing PD-L1 hyperexpression from hypoexpression. Clinical relevance Preliminary results suggest that DCE-MRI could be a safe method to stratify PD-L1 hypo/hyperexpression in non-small cell lung cancer, potentially optimizing treatment decisions, given the high cost of immunotherapy.

European RadiologyVol. 35(9)
University of California, Los Angeles (US), University of Milan (IT), University of Pavia (IT), National Center for Oncological Hadrontherapy (IT), Istituto Nazionale di Fisica Nucleare, Sezione di Pavia (IT), Siemens (Italy) (IT), Policlinico San Matteo Fondazione (IT), Siemens Healthcare (United States) (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Siemens Healthineers (Germany) (DE), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Università della Svizzera italiana (CH)
Fondazione IRCCS Policlinico San Matteo, Università degli Studi di Pavia
Openalex Percentile: Top 7%
Radiomics and Machine Learning in Medical Imaging
4.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.